How many acquisitions has Ipsen made so far?

Ipsen has completed 9 acquisitions so far, with an average acquisition amount of $494M.

Which countries does Ipsen usually acquire in?

Ipsen has made acquisitions in 6 countries with the most activity in United Kingdom and United States.

In which year did Ipsen make the most acquisitions?

Ipsen was most active in 2015, with 2 acquisitions completed in that year.

List of 9 Acquisitions by Ipsen (Jun 2026)

Q: Which is Ipsen's latest acquisition?

Ipsen's most recent acquisition is Imcheck Therapeutics, a Developer of immunotherapeutic antibodies for the treatment of multiple diseases, acquired in December 2025.

Ipsen has completed a total of 9 acquisitions. Peak acquisition years include 2015 with 2, and 2025 and 2023 each with 1. Acquisition activity has spanned 6 countries, with the most frequent in United Kingdom (3), United States (2), and France (1). The acquisitions have covered 8 distinct sectors, prominently Oncology (4), Genomics (1), and Neurology (1). Over the last five years (2020–2025), the average number of acquisitions per year is 0.6, with no acquisitions completed in the current calendar year. The most recent acquisition was Imcheck Therapeutics, acquired in December, 2025. Founded in 2015 and located in Marseille, this company develops immunotherapeutic antibodies for the treatment of multiple diseases.

Here's the year on year acquisition history of Ipsen:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2023	1
2022	1
2019	1
2017	1
2015	2
2013	1
2008	1

View all Acquisitions by Ipsen

Recent acquisitions by Ipsen

Ipsen's most recent acquisition - Imcheck Therapeutics is a Developer of immunotherapeutic antibodies for the treatment of multiple diseases, founded in 2015 and located in Marseille. Ipsen acquired it in December 2025 for a price of $*****.

Here is the list of all acquisitions by Ipsen sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Dec 15, 2025	Imcheck Therapeutics	dbtu	falb	25	816
Jan 09, 2023	Albireo Pharma	pkka	wcnx	38	171
Jun 27, 2022	Epizyme	hrkn	dnmo	43	557
Feb 25, 2019	Clementia	vhjs	sa{f	14	122
Jan 08, 2017	ONIVYDE	vsbd	rkdr	92	732